Company Filing History:
Years Active: 2012-2015
Title: Innovations of Lisa Davidson in Cancer Research
Introduction
Lisa Davidson is a prominent inventor based in Edinburgh, GB. She has made significant contributions to the field of cancer research, particularly through her innovative work on antibodies.
Latest Patents
Lisa Davidson holds 2 patents related to her groundbreaking research. Her latest patents include "Anti ganglioside GD3 antibodies and uses thereof." This invention focuses on complementarity determining region (CDR)-grafted humanized R24 antibodies that bind to the GD3 ganglioside antigen. The humanized antibodies disclosed in her patents exhibit characteristics that are comparable or superior to the murine R24 antibody, making them useful in treating cancer, specifically melanoma.
Career Highlights
Lisa Davidson is affiliated with the Sloan-Kettering Institute for Cancer Research, where she continues to advance her research in the field. Her work has garnered attention for its potential impact on cancer treatment and therapy.
Collaborations
Some of her notable coworkers include Paul B. Chapman and José W. Saldanha, who have collaborated with her on various research projects.
Conclusion
Lisa Davidson's contributions to cancer research through her innovative patents highlight her role as a leading inventor in the field. Her work continues to inspire advancements in cancer treatment and therapy.